GSK Gsk Plc

TIDMGSK

RNS Number : 9751A

GlaxoSmithKline PLC

03 June 2019

GlaxoSmithKline plc

Total Voting Rights and Capital

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following:

The Company's issued share capital as at 31 May 2019 consisted of 5,381,466,396 shares of 25 pence each ('Ordinary Shares'), of which 393,505,950 Ordinary Shares were held in Treasury.

Therefore, the total number of voting rights in the Company is 4,987,960,446. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

V A Whyte

Company Secretary

3 June 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TVRUGURPQUPBGWW

(END) Dow Jones Newswires

June 03, 2019 09:31 ET (13:31 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024

Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024